Chinese officials say the vaccines appear safe after over 60,000 volunteers took part in the trials with no severe adverse reactions reported. But what concerns the public most is when the vaccine candidate will be declared ready for public use. Professor Wu Zhiwei, director of Center for Public Health Research, at Nanjing University Medical School shared his opinion.